New South Wales, Australia

Lawrence Charles Lapointe

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • New South Wales, AU (2021)
  • West Pennant Hills, AU (2019 - 2022)

Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Lawrence Charles Lapointe

Introduction

Lawrence Charles Lapointe is an accomplished inventor based in New South Wales, Australia. He has made significant contributions to the field of medical diagnostics, particularly in colorectal cancer screening. With a total of 4 patents, his work has the potential to impact the way neoplasms are diagnosed and monitored.

Latest Patents

One of his latest patents is a "Diagnostic gene marker panel for colorectal cancer." This invention relates to a method of screening for the onset, predisposition to the onset, and/or progression of a neoplasm. It specifically focuses on changes to the methylation levels of a panel of gene markers, including BCAT1, IKZF1, IRF4, GRASP, and/or CAHM. This method is useful in various applications, including the diagnosis and monitoring of colorectal neoplasms, such as colorectal adenocarcinosis. Another significant patent is the "Method of screening for colorectal cancer," which determines the probabilities of classifying a neoplasm into categories such as adenoma, stage I, stage II, stage III, or stage IV. This method also utilizes changes to the methylation levels of the same panel of gene markers, enhancing the diagnostic capabilities for colorectal neoplasms.

Career Highlights

Lawrence has worked with notable organizations, including Clinical Genomics Pty. Ltd. and the Commonwealth Scientific and Industrial Research Organisation. His experience in these institutions has allowed him to develop and refine his innovative approaches to cancer diagnostics.

Collaborations

Throughout his career, Lawrence has collaborated with esteemed colleagues such as Susanne Kartin Pedersen and Peter Laurence Molloy. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Lawrence Charles Lapointe's contributions to the field of medical diagnostics, particularly in colorectal cancer, demonstrate his innovative spirit and dedication to improving healthcare outcomes. His patents reflect a commitment to advancing diagnostic methods that can significantly benefit patients and healthcare providers alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…